Jxstern 2015-12-09 07:31:54
Dow Jones Business News
FDA Approves Biogen’s Large-Scale Manufacturing Facility For
Friday August 1, 11:30 am ET
CAMBRIDGE, Mass. -(Dow Jones)- Biogen Inc.’s Research Triangle Park,
N.C. manufacturing plant obtained Food and Drug Administration (News –
Websites) approval for the commercial production of Amevive, its
chronic plaque psoriasis drug.
In a press release Friday, the pharmaceutical company said it plans to
use the facility, which has 90,000 liters of bioreactor capacity, to
make future products in its pipeline.